KR102389105B1 - Food composition containing pineapple-derived ceramide as an active ingredient and method for manufacturing the same - Google Patents
Food composition containing pineapple-derived ceramide as an active ingredient and method for manufacturing the same Download PDFInfo
- Publication number
- KR102389105B1 KR102389105B1 KR1020200073754A KR20200073754A KR102389105B1 KR 102389105 B1 KR102389105 B1 KR 102389105B1 KR 1020200073754 A KR1020200073754 A KR 1020200073754A KR 20200073754 A KR20200073754 A KR 20200073754A KR 102389105 B1 KR102389105 B1 KR 102389105B1
- Authority
- KR
- South Korea
- Prior art keywords
- pineapple
- ceramide
- java
- extract
- food composition
- Prior art date
Links
- 229940106189 ceramide Drugs 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 83
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 title claims abstract description 81
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 title claims abstract description 81
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 title claims abstract description 81
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 235000007119 Ananas comosus Nutrition 0.000 title claims abstract description 61
- 244000099147 Ananas comosus Species 0.000 title claims abstract description 53
- 235000013305 food Nutrition 0.000 title claims abstract description 47
- 239000004480 active ingredient Substances 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 240000003731 Piper cubeba Species 0.000 claims abstract description 61
- 235000002711 Piper cubeba Nutrition 0.000 claims abstract description 61
- 241001512940 Curcuma amada Species 0.000 claims abstract description 59
- 235000018453 Curcuma amada Nutrition 0.000 claims abstract description 59
- 102000008186 Collagen Human genes 0.000 claims abstract description 49
- 108010035532 Collagen Proteins 0.000 claims abstract description 49
- 229920001436 collagen Polymers 0.000 claims abstract description 49
- 229940002508 ginger extract Drugs 0.000 claims abstract description 41
- 229940116257 pepper extract Drugs 0.000 claims abstract description 41
- 239000002994 raw material Substances 0.000 claims description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 238000002360 preparation method Methods 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 230000032683 aging Effects 0.000 claims description 21
- 239000008213 purified water Substances 0.000 claims description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 35
- 230000003020 moisturizing effect Effects 0.000 abstract description 13
- 208000007882 Gastritis Diseases 0.000 abstract description 10
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 10
- 201000005917 gastric ulcer Diseases 0.000 abstract description 10
- 235000013376 functional food Nutrition 0.000 abstract description 9
- 230000006872 improvement Effects 0.000 abstract description 7
- 230000009245 menopause Effects 0.000 abstract description 6
- 230000004580 weight loss Effects 0.000 abstract description 6
- 208000011580 syndromic disease Diseases 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 66
- 241000700159 Rattus Species 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 17
- 241000234671 Ananas Species 0.000 description 8
- 206010027304 Menopausal symptoms Diseases 0.000 description 8
- 210000000577 adipose tissue Anatomy 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 6
- 150000003408 sphingolipids Chemical class 0.000 description 5
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 235000004936 Bromus mango Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000014826 Mangifera indica Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 235000009184 Spondias indica Nutrition 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000019510 Long pepper Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 240000003455 Piper longum Species 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 235000012432 gingerbread Nutrition 0.000 description 2
- 150000002305 glucosylceramides Chemical class 0.000 description 2
- 150000002327 glycerophospholipids Chemical class 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001609213 Carassius carassius Species 0.000 description 1
- YBSQGNFRWZKFMJ-UHFFFAOYSA-N Cerebroside B Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O YBSQGNFRWZKFMJ-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000407170 Curcuma Species 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 235000008496 Drimys aromatica Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001093152 Mangifera Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000008202 Schinus molle Species 0.000 description 1
- 235000005151 Schinus molle Nutrition 0.000 description 1
- 235000013880 Schinus terebinthifolius var. raddianus Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- LEBBDRXHHNYZIA-LDUWYPJVSA-N [(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] n-[(z)-1,3-dihydroxyoctadec-4-en-2-yl]carbamate Chemical compound CCCCCCCCCCCCC\C=C/C(O)C(CO)NC(=O)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O LEBBDRXHHNYZIA-LDUWYPJVSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WPIHMWBQRSAMDE-YCZTVTEBSA-N beta-D-galactosyl-(1->4)-beta-D-galactosyl-N-(pentacosanoyl)sphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC WPIHMWBQRSAMDE-YCZTVTEBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019516 cod Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 201000000079 gynecomastia Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Abstract
본 발명은 기능성 식품 조성물에 관한 것으로, 더 자세하게는 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 유효성분으로 포함하여 피부 보습 효과는 물론, 체중 감소 효과, 위염 또는 위궤양 개선 효과, 여성갱년기 증후군 개선 효과 등 다양한 효과를 갖도록 한 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물 및 그 제조방법에 관한 것이다.The present invention relates to a functional food composition, and more particularly, contains pineapple-derived ceramide, collagen, mango ginger extract, and Java pepper extract as active ingredients to provide skin moisturizing effect, as well as weight loss effect, gastritis or gastric ulcer improvement effect, menopause It relates to a food composition comprising pineapple-derived ceramide, which has various effects such as syndrome improvement effect, as an active ingredient, and a method for manufacturing the same.
Description
본 발명은 기능성 식품 조성물에 관한 것으로, 더 자세하게는 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 유효성분으로 포함하여 피부 보습 효과를 갖도록 한 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물 및 그 제조방법에 관한 것이다.The present invention relates to a functional food composition, and more particularly, a food composition comprising pineapple-derived ceramide, collagen, mango ginger extract, and Java pepper extract as active ingredients to have a skin moisturizing effect as an active ingredient, and It relates to a manufacturing method thereof.
현대로 접어들면서, 건강과 미용에 관한 관심이 커지고 있다. 이를 해결하기 위하여 다양한 기능성 식품에 대한 수요가 증가하고 있는 추세이다.As we enter the modern age, interest in health and beauty is growing. In order to solve this problem, the demand for various functional foods is increasing.
기능성 식품의 주된 목적으로 피부 보습을 개선하는 기능을 들 수 있다. 피부는 인간의 신체를 둘러쌓아 보호하는 기능을 하는 것으로 바깥쪽의 표피와 안쪽의 진피와 피하조직의 3 층으로 구분되며, 표피와 진피 사이에 기저막이 존재한다 이 중, 바깥층은 표피(epidermis)라고 하고 중층편평상피로 구성되며 혈관이 없다. 오래된 표피세포의 세포질은 질긴 섬유성 방수물질인 케라틴(keratin)이라는 단백질로 채워지는 각질화(keratinization)를 거쳐 단단해지며, 데스모솜(desmosome)을 통해 서로 강하게 결합함에 따라 강력하고 서로 밀착된 죽은 세포들로 구성된 각질층이 형성된다. 한편, 신체의 건강이 쇠약해지면, 상기 피부의 수분 유지 능력이 떨어지게 되어, 보습과 관련된 효과가 감소하는 문제점이 발생할 수 있다. 이에, 다양한 보습 기능성 식품이 개발되고 있으나, 만족할 만한 효과를 얻기 어렵다는 문제점이 있다.The main purpose of functional food is to improve skin moisture. The skin acts to surround and protect the human body, and is divided into three layers: the outer epidermis, the inner dermis, and the subcutaneous tissue. There is a basement membrane between the epidermis and the dermis. Of these, the outer layer is the epidermis It is composed of stratified squamous epithelium and has no blood vessels. The cytoplasm of old epidermal cells is hardened through keratinization, which is filled with a protein called keratin, a tough fibrous waterproofing material. A stratum corneum composed of On the other hand, when the health of the body is weakened, the ability of the skin to retain moisture is lowered, which may cause a problem in that the effect related to moisturizing is reduced. Accordingly, various moisturizing functional foods have been developed, but there is a problem in that it is difficult to obtain satisfactory effects.
한편, 기능성 식품의 또 다른 목적으로는 체중 감소 효과를 들 수 있다. 현대로 접어들면서, 현대인들의 운동 부족과 식습관의 변화는 비만이라는 결과를 낳게 된다. 비만은 식이조절과 꾸준한 운동으로 개선될 수 있지만, 상당한 노력이 드은 것이 사실이다. 비만이란, 체내에 지방 조직이 과다한 상태를 비만이라고 한다. 체중은 많이 나가지만 근육량이 증가해 있고 지방량이 많지 않은 경우는 비만으로 부르지 않는다. 체질량지수(Body mass index: 체중(kg)을 신장(m)의 제곱으로 나눈 값)가 25 이상이면 비만으로 정의한다(서양인은 30 이상이며, 인종간의 차이를 고려하여 우리나라에서는 25 이상을 비만으로 정의하나 이 기준에 대해서는 아직 논란이 있음). 지방 조직의 주요 성분은 혈장으로부터 유입된 지방산과 포도당이 에스테르화한 중성지방이다. 때문에, 이러한 비만을 해소할 수 있는 기능성 식품에 대한 연구가 활발히 진행중이나, 만족할 만한 효과를 얻기 어려운 것이 현실이다.On the other hand, another purpose of the functional food may be a weight loss effect. As we enter the modern age, lack of exercise and changes in eating habits of modern people lead to obesity. Obesity can be improved with diet control and regular exercise, but it is true that considerable effort is required. Obesity is a condition in which there is an excess of adipose tissue in the body. If you have a lot of weight but have increased muscle mass and not much fat, it is not called obesity. If the body mass index (body mass index: weight (kg) divided by the square of height (m)) is 25 or more, it is defined as obesity (30 or more for Westerners, and 25 or more is considered obese in Korea, considering racial differences) definition, but this criterion is still controversial). The main components of adipose tissue are triglycerides obtained by esterification of fatty acids and glucose from plasma. Therefore, although research on functional foods capable of resolving such obesity is actively in progress, it is difficult to obtain satisfactory effects.
한편, 현대인들은 자극적인 음식을 먹는 식습관과, 먹고 바로 눕는 습관에 따라 위와 관련된 문제가 발생하고 있다, 대표적으로 위염과 위궤양을 들 수 있는데, 이들을 예방, 개선하기 위한 다양한 식품들이 개발 중이나 아직은 뚜렷한 효과를 얻기 힘들다는 문제점이 있다. 그 외에, 여성갱년기 증후군 등 다양한 증상 등에 대한 연구가 아직은 부족한 실정이다.On the other hand, modern people are experiencing stomach-related problems depending on their eating habits and habits of eating and lying down right after eating. There is a problem that it is difficult to obtain. In addition, studies on various symptoms such as female menopause syndrome are still insufficient.
이에 따라, 보습 기능 개선과 더불어 인체에 대한 다양한 효능을 갖는 식품 조성물에 대한 연구가 활발히 진행중이다. Accordingly, research on a food composition having various effects on the human body as well as improving the moisturizing function is being actively conducted.
상기와 같은 문제점을 해결하기 위하여 본 발명은 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 유효성분으로 포함하여 피부 보습 효과를 갖도록 한 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물을 제공하는데 목적이 있다. In order to solve the above problems, the present invention provides a food composition comprising pineapple-derived ceramide, collagen, mango ginger extract, and Java pepper extract as active ingredients to have a skin moisturizing effect as an active ingredient. There is a purpose.
또한, 본 발명은 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 포함하여 체중 감소 효과, 위염 또는 위궤양 개선 효과, 여성갱년기 증후군 개선 효과를 추가로 갖는 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물을 제공하는데 목적이 있다. In addition, the present invention includes pineapple-derived ceramide, collagen, mango ginger extract, and Java pepper extract, including weight loss effect, gastritis or gastric ulcer improvement effect, and pineapple-derived ceramide having an effect of improving female menopausal syndrome as an active ingredient. It is an object to provide a composition.
본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 유효성분으로 포함하여 피부 보습 효과를 갖는다.The food composition comprising pineapple-derived ceramide according to the present invention as an active ingredient contains pineapple-derived ceramide, collagen, mango ginger extract and Java pepper extract as active ingredients to have a skin moisturizing effect.
또한, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 포함하여 체중 감소 효과, 위염 또는 위궤양 개선 효과, 여성갱년기 증후군 개선 효과를 추가로 갖는다.In addition, the food composition comprising pineapple-derived ceramide according to the present invention as an active ingredient contains pineapple-derived ceramide, collagen, mango ginger extract, and Java pepper extract to reduce weight, improve gastritis or gastric ulcer, and improve female menopausal syndrome. have additional
도 1은 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조방법을 나타낸 플로우차트.1 is a flowchart showing a method for preparing a food composition comprising a pineapple-derived ceramide according to the present invention as an active ingredient.
이하의 본 발명에 관한 상세한 설명들은 본 발명이 실시될 수 있는 실시 예이고 해당 실시 예의 예시로써 도시된 첨부 도면을 참조한다. 이들 실시 예는 당 업자가 본 발명의 실시에 충분하도록 상세히 설명된다. 본 발명의 다양한 실시 예는 서로 다르지만 상호 배타적일 필요는 없음이 이해되어야 한다. 예를 들어, 여기에 기재되어 있는 특정 형상, 구조 및 특성은 일 실시 예에 관련하여 본 발명의 사상 및 범위를 벗어나지 않으면서 다른 실시 예로 구현될 수 있다. 또한, 각각의 기재된 실시 예 내의 개별 구성요소의 위치 또는 배치는 본 발명의 사상 및 범위를 벗어나지 않으면서 변경될 수 있음이 이해되어야 한다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The following detailed description of the present invention is an embodiment in which the present invention may be practiced, and reference is made to the accompanying drawings shown by way of example of the embodiment. These embodiments are described in sufficient detail to enable those skilled in the art to practice the present invention. It should be understood that various embodiments of the present invention are different but need not be mutually exclusive. For example, specific shapes, structures, and characteristics described herein may be implemented in other embodiments without departing from the spirit and scope of the present invention in relation to one embodiment. In addition, it should be understood that the position or arrangement of individual components in each described embodiment may be changed without departing from the spirit and scope of the present invention.
따라서 후술되는 상세한 설명은 한정적인 의미로서 취하려는 것이 아니며, 본 발명의 범위는 적절하게 설명된다면 그 청구항들이 주장하는 것과 균등한 모든 범위와 더불어 첨부된 청구항에 의해서만 한정된다. 도면에서 유사한 참조부호는 여러 측면에 걸쳐서 동일하거나 유사한 기능을 지칭한다.Accordingly, the detailed description set forth below is not intended to be taken in a limiting sense, and the scope of the present invention, if properly described, is limited only by the appended claims, along with all scopes equivalent to those claimed by the claims. Like reference numerals in the drawings refer to the same or similar functions throughout the various aspects.
본 발명에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.The terms used in the present invention have been selected as currently widely used general terms as possible while considering the functions in the present invention, which may vary depending on the intention or precedent of a person skilled in the art, the emergence of new technology, and the like. In addition, in a specific case, there is a term arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the corresponding invention. Therefore, the term used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, rather than the name of a simple term.
본 발명에서 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.In the present invention, when a part "includes" a certain component, it means that other components may be further included, rather than excluding other components, unless otherwise stated.
이하, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물 및 그 제조방법에 대하여 자세히 설명한다.Hereinafter, a food composition comprising a pineapple-derived ceramide according to the present invention as an active ingredient and a method for manufacturing the same will be described in detail.
본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 포함하는 것을 특징으로 한다.The food composition comprising pineapple-derived ceramide as an active ingredient according to the present invention is characterized in that it comprises ceramide, collagen, mango ginger extract and Java pepper extract.
상기 세라마이드(ceramide)는 스핑고지질(sphingolipid)의 한 종류로서 스핑고신(sphingosine)과 지방산으로 구성된 분자이다. 세라마이드는 세포막에 다량으로 존재하고 있으며, 세포분화, 성장, 사멸 등의 다양한 세포 신호전달에 관여하고 있다. The ceramide (ceramide) is a type of sphingolipid and is a molecule composed of sphingosine and fatty acids. Ceramide exists in a large amount in the cell membrane and is involved in various cell signaling such as cell differentiation, growth, and death.
상기 스핑고지질은 세포막을 구성하는 지질로서 1개의 극성 머리 부분과 2개의 비극성 꼬리 부분을 가지고 있으나 글리세로인지질(glycerophospholipid)과 갈락토지질(galactolipid)과 달리 글리세롤을 함유하고 있지 않다. 스핑고지질은 18개의 탄소로 구성된 아미노알코올인 스핑고신 또는 그 유도체 1분자, 긴 사슬의 지방산 1분자, 글라코사이드 결합 또는 인산에스터 결합을 통하여 연결되어 있는 극성 머리부분으로 구성되어 있다. 스핑고신의 1, 2, 3번 탄소들은 글리세로인지질의 글리세롤에 있는 3개의 탄소기와 구조적으로 유사하다. 스핑고신의 2번 탄소의 아미노기에 아마이드 결합으로 지방산이 연결되면 세라마이드가 형성되며, 이 분자는 다이아실글리세롤(diacylgycerol)과 구조적으로 유사하다. 세라마이드는 모든 스핑고지질에서 공통적인 기본 구조골격이다. 스핑고지질에는 세라마이드 외에 머리부분이 다른 3종류의 아류, 즉 스핑고마이엘린(sphingomyelin), 중성 당지질(neutral glycolipid), 강글리오사이드(ganglioside) 등이 있다.The sphingolipid is a lipid constituting a cell membrane and has one polar head and two non-polar tails, but unlike glycerophospholipids and galactolipids, it does not contain glycerol. A sphingolipid is composed of one molecule of sphingosine or a derivative thereof, an amino alcohol composed of 18 carbons, one molecule of long-chain fatty acid, and a polar head connected through a glycosidic bond or a phosphate ester bond. Carbons 1, 2, and 3 of sphingosine are structurally similar to the three carbon groups in glycerol of glycerophospholipids. When a fatty acid is linked by an amide bond to the amino group of carbon 2 of sphingosine, a ceramide is formed, and this molecule is structurally similar to diacylglycerol. Ceramides are the basic structural framework common to all sphingolipids. In addition to ceramides, there are three subtypes of sphingolipids with different heads, namely sphingomyelin, neutral glycolipid, and ganglioside.
본 발명에 있어서, 세라마이드는 당 세라마이드인 것이 적절하다. 상기 세라마이드는 당 업계에서 통상적으로 유통되는 것을 구매하여 이용할 수 있다. In the present invention, it is appropriate that the ceramide is a sugar ceramide. The ceramide can be purchased and used that are commonly distributed in the industry.
상기 당 세라마이드로는 통상적으로 알려진 일반적인 물질들을 모두 사용 가능하며, 예를 들어, 글루코실세라마이드, 락토실세라마이드, 갈락토실세라마이드, 갈락토세레브로사이드, 글루코세레브로사이드 등을 사용할 수 있을 것이다. As the sugar ceramide, all commonly known substances can be used, and for example, glucosyl ceramide, lactosyl ceramide, galactosyl ceramide, galactocerebroside, glucocerebroside, and the like may be used.
다만, 본 발명에서 다루는 세라마이드는 파인애플로부터 추출한 세라마이드, 즉, 파인애플 유래의 세라마이드, 즉, 글루코실세라마이드인 것이 가장 바람직할 것이다. However, the ceramide dealt with in the present invention will be most preferably a ceramide extracted from pineapple, that is, a ceramide derived from pineapple, that is, glucosylceramide.
상기 콜라겐(collagen)은 흔히 교원질이라고도 불리며, 대부분의 동물, 특히 포유동물에서 많이 발견되는 섬유 단백질로, 피부와 연골 등 체내의 모든 결합조직의 대부분을 차지한다. 콜라겐은 폴리펩타이드 세 분자가 서로 삼중나선으로 꼬인 밧줄과 같은 형태를 이루고 있다. 각각의 폴리펩타이드 사슬은 글라이신과 프롤린이 서로 번갈아가면서 배치되고 중간에 여러 다른 아미노산이 군데군데 삽입되어 있다. 대표적으로 라이신과 프롤린에서 각각 유도된 하이드록시라이신과 하이드록시프롤린이 있다. 이 둘은 수소결합을 통해 사슬끼리 서로 단단히 연결되는 4차 구조 형성에 중요한 역할을 한다. 이러한 구조 덕분에 콜라겐은 매우 강하여 장력에 잘 견디고 장기간 분해되지 않으나, 섭씨 약 37도 이상의 온도에서는 폴리펩타이드 간 연결이 약해지는 경향을 보인다.The collagen is often called collagen, and is a fibrous protein found in most animals, particularly mammals, and occupies most of all connective tissues in the body, such as skin and cartilage. Collagen is like a rope in which three polypeptide molecules are twisted into a triple helix. In each polypeptide chain, glycine and proline are alternately arranged with each other, and several different amino acids are inserted in the middle. Representatively, there are hydroxylysine and hydroxyproline derived from lysine and proline, respectively. These two play an important role in the formation of a quaternary structure in which chains are tightly connected to each other through hydrogen bonds. Thanks to this structure, collagen is very strong, withstands tension well, and does not decompose for a long time.
본 발명에 있어서, 콜라겐은 통상적으로 시판되는 것을 이용하는 것이 바람직하며, 어류 또는 육류로부터 추출된 콜라겐인 것이 적절할 것이다.In the present invention, it is preferable to use a commercially available collagen, and collagen extracted from fish or meat will be appropriate.
보다 구체적으로 상기 콜라겐은 참치, 연어, 고등어, 대구, 잉어, 붕어 등의 어류나, 소, 돼지, 닭, 양, 말, 오리 등의 육류로부터 추출된 콜라겐인 것이 바람직할 것이다.More specifically, the collagen is preferably collagen extracted from fish such as tuna, salmon, mackerel, cod, carp, crucian carp, or meat such as cattle, pig, chicken, sheep, horse, and duck.
상기 망고진저 추출물은 망고진저로부터 추출한 추출물을 칭한다.The mango ginger extract refers to an extract extracted from mango ginger.
상기 망고진저(curcuma amada)는 뿌리줄기의 형태가 생강과 비슷하지만, 그 맛은 생 망고의 맛이 나는 인도산 식물로, 남부 인도에서는 피클을 만들고, 북부 인도에서는 차트니를 만드는데 사용한다. 상기 망고진저는 zingiberaceae과 Curcuma속의 식물로 키가 약 80cm 정도로 자라는 다년생 식물이다. 상기 망고진저는 열대지방에서 주로 자라며 인도, 방글라데시, 미얀마, 태국 등지에서 재배된다. 상기 망고진저의 뿌리에는 에센셜 오일이 포함되어 있으며, 전통적으로 기침이나 기관지염과 같은 치료에 사용하였고 으깬 뿌리를 궤양, 타박상, 상처 및 염좌에 발라 환부를 치료하기도 하였다. 본 발명에 있어서, 망고진저라 함은 망고진저(curcuma amada)의 뿌리줄기를 일컫는다.The mango ginger ( curcuma amada ) is similar to ginger in the form of a rhizome, but the taste is an Indian plant with the taste of raw mango, and is used to make pickles in southern India and to make chartney in northern India. The mango ginger is a plant of the genus zingiberaceae and Curcuma , and is a perennial plant that grows to about 80 cm in height. The mango ginger is mainly grown in the tropics and is cultivated in India, Bangladesh, Myanmar, Thailand, and the like. The root of the mango ginger contains essential oil, and has traditionally been used to treat cough or bronchitis, and the crushed root is applied to ulcers, bruises, wounds and sprains to treat the affected areas. In the present invention, the mango ginger refers to the rhizome of mango ginger ( curcuma amada ).
상기 망고진저 추출물은 망고진저를 분쇄하고 정제수, 에탄올, 부탄올, 부틸렌글라이콜 또는 이소프로판올 중 어느 하나 이상의 추출용매로 추출한 것이 바람직하다.The mango ginger extract is preferably ground mango ginger and extracted with at least one extraction solvent of purified water, ethanol, butanol, butylene glycol, or isopropanol.
상기 자바후추 추출물은 자바후추로부터 추출한 추출물을 칭한다.The Java pepper extract refers to an extract extracted from Java pepper.
상기 자바후추(piper retrofractum)는 수마트라, 페낭, 뉴기니아에서 자생하는 후추나무로 담쟁이덩굴처럼 감겨서 성장하는 것이 특징이다. 상기 자바후추에서 향신료로 이용하는 것은 열매로 이것을 쿠베브라고 부른다. 상기 자바후추는 덜 익은 열매를 수확하여 건조한 후 향신료로 쓴다. 열매에는 작은 꼬리가 달려 있고 건조하면 주름진 가죽처럼 변한다. 상기 자바후추는 흑후추와 같은 종으로 모양과 맛이 비슷하고 아주 매운 향신료이다. 상기 자바후추는 건조한 것을 분말이나 엑기스 형태로 이용하거나 정제 후 정유를 추출하여 이용한다. 상기 자바후추의 정유는 소스, 양념, 비터스, 담배 등의 맛을 내는데 쓰거나 향유나 세면용품 제조에 쓴다. 다. 본 발명에 있어서, 자바후추라 함은 자바후추(piper retrofractum)의 열매를 일컫는다.The Java pepper ( piper retrofractum ) is a pepper tree that grows wild in Sumatra, Penang, and New Guinea, and is characterized by being wound up like an ivy. In the Java pepper, it is a fruit that is used as a spice, and this is called kubev. The Java pepper is used as a spice after the unripe fruit is harvested and dried. The fruit has a small tail, and when it dries, it turns into a wrinkled hide. The Java pepper is the same species as black pepper and has a similar shape and taste, and is a very spicy spice. The Java pepper is used in the form of a powder or extract dried, or by extracting essential oil after purification. The essential oil of Java pepper is used to flavor sauces, seasonings, bitters, tobacco, and the like, or used to manufacture perfume oil or toiletries. all. In the present invention, Java pepper refers to the fruit of Java pepper ( piper retrofractum ).
상기 자바후추 추출물은 자바후추를 분쇄하고 정제수, 에탄올, 부탄올, 부틸렌글라이콜 또는 이소프로판올 중 어느 하나 이상의 추출용매로 추출한 것이 바람직하다.The Java pepper extract is preferably extracted with any one or more extraction solvents of purified water, ethanol, butanol, butylene glycol, and isopropanol after grinding Java pepper.
본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 세라마이드가 50 ~ 60 중량%, 콜라겐이 20 ~ 30 중량%, 망고진저 추출물이 5 ~ 10 중량%, 자바후추 추출물이 5 ~ 10 중량%로 포함될 수 있다. 또한, 잔량의 정제수를 더 포함할 수 있다.The food composition comprising pineapple-derived ceramide according to the present invention as an active ingredient contains 50 to 60% by weight of ceramide, 20 to 30% by weight of collagen, 5 to 10% by weight of mango ginger extract, and 5 to 10% by weight of Java pepper extract % may be included. In addition, it may further include a residual amount of purified water.
상기 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물은 서로 혼합되는 것이 바람직하며, 예컨데, 50 ~ 200rpm의 속도로 혼합될 수 있다.The ceramide, collagen, mango ginger extract and Java pepper extract are preferably mixed with each other, for example, may be mixed at a speed of 50 ~ 200rpm.
한편, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 혼합하여 혼합물을 형성한 상태에서 12 내지 48시간 동안 숙성한 것일 수 있다. 숙성은 10 ~ 25℃, 즉 실온으로 이루어지는 것이 바람직할 것이다.On the other hand, the food composition comprising pineapple-derived ceramide according to the present invention as an active ingredient may be aged for 12 to 48 hours in a state of forming a mixture by mixing ceramide, collagen, mango ginger extract and Java pepper extract. Aging may be preferably performed at 10 to 25° C., that is, room temperature.
이하, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조방법에 대하여 자세히 설명한다.Hereinafter, a method for preparing a food composition comprising a pineapple-derived ceramide according to the present invention as an active ingredient will be described in detail.
본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조방법은 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 준비하는 원료 준비 단계(S10), 상기 원료 준비 단계(S10)에서 준비된 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 혼합하여 혼합물을 제조하는 원료 혼합 단계(S20) 및, 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 상온에서 숙성하는 숙성 단계(S30)를 포함한다.The method for preparing a food composition comprising pineapple-derived ceramide as an active ingredient according to the present invention is a raw material preparation step (S10) of preparing ceramide, collagen, mango ginger extract and Java pepper extract, ceramide prepared in the raw material preparation step (S10) , a raw material mixing step (S20) of preparing a mixture by mixing collagen, mango ginger extract and Java pepper extract, and an aging step (S30) of aging the mixture prepared in the raw material mixing step (S20) at room temperature.
우선, 원료 준비 단계(S10)를 수행한다.First, the raw material preparation step (S10) is performed.
상기 원료 준비 단계(S10)에서는 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 준비한다.In the raw material preparation step (S10), ceramide, collagen, mango ginger extract and Java pepper extract are prepared.
상기 원료 준비 단계(S10)에서의 세라마이드는, 파인애플 유래의 세라마이드인 것이 바람직하다. 상기 파인애플 유래 세라마이드는 당 업계에서 통상적으로 유통되는 것을 구매하여 이용할 수 있다. 혹은, 파인애플로부터 세라마이드를 직접 추출하여 얻을 수도 있고, 그 외에 다양한 방법을 통해 준비될 수 있으며, 이를 한정하지 않는다.The ceramide in the raw material preparation step (S10) is preferably a ceramide derived from pineapple. The pineapple-derived ceramide can be purchased and used that are commonly distributed in the industry. Alternatively, it may be obtained by directly extracting ceramide from pineapple, and may be prepared through various other methods, but is not limited thereto.
또한, 상기 원료 준비 단계(S10)에서의 콜라겐은 통상적으로 시판되는 것을 이용하는 것이 바람직하며, 어류 또는 육류로부터 추출된 콜라겐인 것이 적절할 것이다.In addition, it is preferable to use a commercially available collagen in the raw material preparation step (S10), and it will be appropriate to use collagen extracted from fish or meat.
또한, 상기 원료 준비 단계(S10)에서의 망고진저 추출물은 망고진저를 분쇄하고 정제수, 에탄올, 부탄올, 부틸렌글라이콜 또는 이소프로판올 중 어느 하나 이상의 추출용매로 추출한 것이 바람직하다.In addition, the mango ginger extract in the raw material preparation step (S10) is preferably ground mango ginger and extracted with at least one extraction solvent of purified water, ethanol, butanol, butylene glycol, or isopropanol.
또한, 상기 원료 준비 단계(S10)에서의 자바후추 추출물은 자바후추를 분쇄하고 정제수, 에탄올, 부탄올, 부틸렌글라이콜 또는 이소프로판올 중 어느 하나 이상의 추출용매로 추출한 것이 바람직하다.In addition, it is preferable that the Java pepper extract in the raw material preparation step (S10) is extracted with any one or more extraction solvents of purified water, ethanol, butanol, butylene glycol, and isopropanol by grinding Java pepper.
다음으로, 원료 혼합 단계(S20)를 수행한다.Next, the raw material mixing step (S20) is performed.
상기 원료 혼합 단계(S20)에서는 상기 원료 준비 단계(S10)에서 준비된 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 혼합하여 혼합물을 제조한다. In the raw material mixing step (S20), the ceramide, collagen, mango ginger extract and Java pepper extract prepared in the raw material preparation step (S10) are mixed to prepare a mixture.
상기 원료 혼합 단계(S20)에서는 세라마이드 50 ~ 60 중량%, 콜라겐 20 ~ 30 중량%, 망고진저 추출물 5 ~ 10 중량%, 자바후추 추출물 5 ~ 10 중량%가 되도록 혼합할 수 있다. 또한, 잔량은 정제수로 채우는 것이 바람직하다.In the raw material mixing step (S20), 50 to 60% by weight of ceramide, 20 to 30% by weight of collagen, 5 to 10% by weight of mango ginger extract, and 5 to 10% by weight of Java pepper extract may be mixed. In addition, it is preferable to fill the remainder with purified water.
상기 원료 혼합 단계(S20)에서 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물은 하나의 용기에 담고, 50 ~ 200rpm의 속도로 교반함으로써 혼합물을 형성할 수 있다.In the raw material mixing step (S20), ceramide, collagen, mango ginger extract, and Java pepper extract may be put in one container, and a mixture may be formed by stirring at a speed of 50 to 200 rpm.
다음으로, 숙성 단계(S30)를 수행한다.Next, the aging step (S30) is performed.
상기 숙성 단계(S30)에서는 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 숙성한다.In the aging step (S30), the mixture prepared in the raw material mixing step (S20) is aged.
상기 숙성 단계(S30)에서의 숙성시간은 12 내지 48시간 동안 이루어질 수 있으며, 상기 숙성 단계(S30)에서의 숙성온도는 10 ~ 25℃로 수행되는 것이 바람직할 것이다.The aging time in the aging step (S30) may be made for 12 to 48 hours, and the aging temperature in the aging step (S30) is preferably performed at 10 to 25°C.
숙성 단계(S30)까지 완료하고 나면, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물이 완성되며, 상기 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 피부 보습 효과를 가짐은 물론, 체중 감소 효과, 위염 또는 위궤양 개선 효과, 여성갱년기 증후군 효과를 추가적으로 가질 수 있다.After completing the aging step (S30), the food composition comprising the pineapple-derived ceramide according to the present invention as an active ingredient is completed, and the food composition comprising the pineapple-derived ceramide as an active ingredient has a skin moisturizing effect, It may additionally have a weight loss effect, an effect of improving gastritis or gastric ulcer, and an effect of gynecomastia syndrome.
이하, 하기의 실시예, 비교예, 실험예를 통하여, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물이 갖는 효과에 대하여 자세히 설명한다.Hereinafter, through the following Examples, Comparative Examples, and Experimental Examples, the effect of the food composition comprising the pineapple-derived ceramide according to the present invention as an active ingredient will be described in detail.
실시예Example 1. 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조 1. Preparation of a food composition comprising pineapple-derived ceramide as an active ingredient
하기의 제조과정에 따라, 실시예 1의 식품조성물을 제조하였다.According to the following manufacturing process, the food composition of Example 1 was prepared.
원료 준비 단계(S10): 파인애플 유래의 세라마이드와, 콜라겐을 준비하였으며, 망고진저 및 자바후추를 각각 정제수 및 에탄올을 포함하는 추출용매로 추출하여 망고진저 추출물과 자바후추 추출물을 준비하였다.Raw material preparation step (S10): Pineapple-derived ceramide and collagen were prepared, and mango ginger and Java pepper were extracted with an extraction solvent containing purified water and ethanol, respectively, to prepare mango ginger extract and Java pepper extract.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 파인애플 유래의 세라마이드, 콜라겐, 망고진저 추출물과 자바후추 추출물을 하나의 용기에 넣고 혼합하되, 파인애플 유래 세라마이드 50 중량%, 콜라겐 20 중량%, 망고진저 추출물 5 중량%, 자바후추 추출물 5 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): Pineapple-derived ceramide, collagen, mango ginger extract and Java pepper extract prepared in the raw material preparation step (S10) are mixed in one container and mixed, but pineapple-derived ceramide 50% by weight, collagen 20% by weight , 5 wt% of mango ginger extract, 5 wt% of Java pepper extract, and purified water as the remaining amount were mixed with stirring at a speed of 50 to 200 rpm to prepare a mixture.
숙성 단계(S30): 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 24시간 동안 15℃로 숙성하였다.Aging step (S30): The mixture prepared in the raw material mixing step (S20) was aged at 15° C. for 24 hours.
비교예comparative example 1. 파인애플 유래의 세라마이드를 배제한 식품 조성물의 제조 1. Preparation of food composition excluding ceramide derived from pineapple
하기의 제조과정에 따라, 비교예 1의 식품 조성물을 제조하였다. 실시예 1과 같은 제조과정을 수행하되, 파인애플 유래의 세라마이드를 제외하고 식품 조성물을 제조하였다.According to the following manufacturing process, the food composition of Comparative Example 1 was prepared. A food composition was prepared in the same manner as in Example 1, except for ceramide derived from pineapple.
원료 준비 단계(S10): 콜라겐을 준비하였으며, 망고진저 및 자바후추를 각각 정제수 및 에탄올을 포함하는 추출용매로 추출하여 망고진저 추출물과 자바후추 추출물을 준비하였다.Raw material preparation step (S10): Collagen was prepared, and mango ginger extract and Java pepper extract were prepared by extracting mango ginger and Java pepper with an extraction solvent containing purified water and ethanol, respectively.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 콜라겐, 망고진저 추출물과 자바후추 추출물을 하나의 용기에 넣고 혼합하되, 콜라겐 20 중량%, 망고진저 추출물 5 중량%, 자바후추 추출물 5 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): The collagen, mango ginger extract and Java pepper extract prepared in the raw material preparation step (S10) are put in one container and mixed, but collagen 20% by weight, mango ginger extract 5% by weight, Java pepper extract 5 A mixture was prepared by mixing with stirring at a speed of 50 to 200 rpm, including purified water as a weight % and the remaining amount.
숙성 단계(S30): 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 24시간 동안 15℃로 숙성하였다.Aging step (S30): The mixture prepared in the raw material mixing step (S20) was aged at 15° C. for 24 hours.
비교예comparative example 2. 콜라겐을 배제한 식품 조성물의 제조 2. Preparation of food composition excluding collagen
하기의 제조과정에 따라, 비교예 2의 식품 조성물을 제조하였다. 실시예 1과 같은 제조과정을 수행하되, 콜라겐을 제외하고 식품 조성물을 제조하였다.According to the following manufacturing process, the food composition of Comparative Example 2 was prepared. A food composition was prepared in the same manner as in Example 1, except for collagen.
원료 준비 단계(S10): 파인애플 유래의 세라마이드를 준비하였으며, 망고진저 및 자바후추를 각각 정제수 및 에탄올을 포함하는 추출용매로 추출하여 망고진저 추출물과 자바후추 추출물을 준비하였다.Raw material preparation step (S10): Pineapple-derived ceramide was prepared, and mango ginger and Java pepper were extracted with an extraction solvent containing purified water and ethanol, respectively, to prepare a mango ginger extract and a Java pepper extract.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 파인애플 유래의 세라마이드, 망고진저 추출물과 자바후추 추출물을 하나의 용기에 넣고 혼합하되, 파인애플 유래 세라마이드 50 중량%, 망고진저 추출물 5 중량%, 자바후추 추출물 5 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): Pineapple-derived ceramide, mango ginger extract and Java pepper extract prepared in the raw material preparation step (S10) are mixed in one container and mixed, but pineapple-derived ceramide 50 wt%, mango ginger extract 5 wt% , including 5% by weight of Java pepper extract and purified water as the remaining amount, and mixing with stirring at a speed of 50 to 200 rpm to prepare a mixture.
숙성 단계(S30): 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 24시간 동안 15℃로 숙성하였다.Aging step (S30): The mixture prepared in the raw material mixing step (S20) was aged at 15° C. for 24 hours.
비교예comparative example 3. 3. 망고진저Gingerbread Mango 추출물 및 extract and 자바후추Java pepper 추출물을 배제한 식품 조성물의 제조 Preparation of food composition excluding extract
하기의 제조과정에 따라, 비교예 3의 식품 조성물을 제조하였다. 실시예 1과 같은 제조과정을 수행하되, 망고진저 추출물 및 자바후추 추출물을 제외하고 식품 조성물을 제조하였다.According to the following manufacturing process, the food composition of Comparative Example 3 was prepared. A food composition was prepared in the same manner as in Example 1, except for the mango ginger extract and the Java pepper extract.
원료 준비 단계(S10): 파인애플 유래의 세라마이드와, 콜라겐을 준비하였다.Raw material preparation step (S10): Pineapple-derived ceramide and collagen were prepared.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 파인애플 유래의 세라마이드, 콜라겐을 하나의 용기에 넣고 혼합하되, 파인애플 유래 세라마이드 50 중량%, 콜라겐 20 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): Put the pineapple-derived ceramide and collagen prepared in the raw material preparation step (S10) in one container and mix, including 50% by weight of pineapple-derived ceramide, 20% by weight of collagen, and purified water as the remaining amount A mixture was prepared by mixing while stirring at a speed of ~ 200 rpm.
숙성 단계(S30): 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 24시간 동안 15℃로 숙성하였다.Aging step (S30): The mixture prepared in the raw material mixing step (S20) was aged at 15° C. for 24 hours.
비교예comparative example 4. 4. 망고진저Gingerbread Mango 추출물을 배제한 식품 조성물의 제조 Preparation of food composition excluding extract
하기의 제조과정에 따라, 비교예 4의 식품 조성물을 제조하였다. 실시예 1과 같은 제조과정을 수행하되, 망고진저 추출물을 제외하고 식품 조성물을 제조하였다.According to the following manufacturing process, the food composition of Comparative Example 4 was prepared. A food composition was prepared in the same manner as in Example 1, except for the mango ginger extract.
원료 준비 단계(S10): 파인애플 유래의 세라마이드와, 콜라겐을 준비하였으며, 자바후추를 정제수 및 에탄올을 포함하는 추출용매로 추출하여 자바후추 추출물을 준비하였다.Raw material preparation step (S10): Ceramide derived from pineapple and collagen were prepared, and Java pepper extract was prepared by extracting Java pepper with an extraction solvent containing purified water and ethanol.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 파인애플 유래의 세라마이드, 콜라겐과 자바후추 추출물을 하나의 용기에 넣고 혼합하되, 파인애플 유래 세라마이드 50 중량%, 콜라겐 20 중량%, 자바후추 추출물 5 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): Put the pineapple-derived ceramide, collagen and Java pepper extract prepared in the raw material preparation step (S10) in one container and mix, but pineapple-derived ceramide 50% by weight, collagen 20% by weight, Java pepper extract A mixture was prepared by mixing with stirring at a speed of 50 to 200 rpm, including purified water at 5 wt % and the remaining amount.
숙성 단계(S30): 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 24시간 동안 15℃로 숙성하였다.Aging step (S30): The mixture prepared in the raw material mixing step (S20) was aged at 15° C. for 24 hours.
비교예comparative example 5. 5. 자바후추Java pepper 추출물을 배제한 식품 조성물의 제조 Preparation of food composition excluding extract
하기의 제조과정에 따라, 비교예 5의 식품 조성물을 제조하였다. 실시예 1과 같은 제조과정을 수행하되, 자바후추 추출물을 제외하고 식품 조성물을 제조하였다.According to the following manufacturing process, the food composition of Comparative Example 5 was prepared. A food composition was prepared in the same manner as in Example 1, except for the Java pepper extract.
원료 준비 단계(S10): 파인애플 유래의 세라마이드와, 콜라겐을 준비하였으며, 망고진저를 정제수 및 에탄올을 포함하는 추출용매로 추출하여 망고진저 추출물을 준비하였다.Raw material preparation step (S10): Pineapple-derived ceramide and collagen were prepared, and mango ginger extract was prepared by extracting mango ginger with an extraction solvent containing purified water and ethanol.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 파인애플 유래의 세라마이드, 콜라겐과 망고진저 추출물을 하나의 용기에 넣고 혼합하되, 파인애플 유래 세라마이드 50 중량%, 콜라겐 20 중량%, 망고진저 추출물 5 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): Put the pineapple-derived ceramide, collagen and mango ginger extract prepared in the raw material preparation step (S10) in one container and mix, but pineapple-derived ceramide 50% by weight, collagen 20% by weight, mango ginger extract A mixture was prepared by mixing with stirring at a speed of 50 to 200 rpm, including purified water at 5 wt % and the remaining amount.
숙성 단계(S30): 상기 원료 혼합 단계(S20)에서 제조된 혼합물을 24시간 동안 15℃로 숙성하였다.Aging step (S30): The mixture prepared in the raw material mixing step (S20) was aged at 15° C. for 24 hours.
비교예comparative example 6. 숙성단계를 배제한 식품조성물의 제조 6. Manufacture of food composition excluding aging stage
하기의 제조과정에 따라, 비교예 3의 식품 조성물을 제조하였다. 실시예 1과 같은 제조과정을 수행하되, 숙성 단계(S30)을 실시하지 않았다.According to the following manufacturing process, the food composition of Comparative Example 3 was prepared. The same manufacturing process as in Example 1 was performed, but the aging step (S30) was not performed.
원료 준비 단계(S10): 파인애플 유래의 세라마이드와, 콜라겐을 준비하였으며, 망고진저 및 자바후추를 각각 정제수 및 에탄올을 포함하는 추출용매로 추출하여 망고진저 추출물과 자바후추 추출물을 준비하였다.Raw material preparation step (S10): Pineapple-derived ceramide and collagen were prepared, and mango ginger and Java pepper were extracted with an extraction solvent containing purified water and ethanol, respectively, to prepare mango ginger extract and Java pepper extract.
원료 혼합 단계(S20): 상기 원료 준비 단계(S10)에서 준비된 파인애플 유래의 세라마이드, 콜라겐, 망고진저 추출물과 자바후추 추출물을 하나의 용기에 넣고 혼합하되, 파인애플 유래 세라마이드 50 중량%, 콜라겐 20 중량%, 망고진저 추출물 5 중량%, 자바후추 추출물 5 중량% 및 잔량으로 정제수를 포함하여 50 ~ 200rpm의 속도로 교반하면서 혼합하여 혼합물을 제조하였다.Raw material mixing step (S20): Pineapple-derived ceramide, collagen, mango ginger extract and Java pepper extract prepared in the raw material preparation step (S10) are mixed in one container and mixed, but pineapple-derived ceramide 50 wt%, collagen 20 wt% , including 5 wt% of mango ginger extract, 5 wt% of Java pepper extract, and purified water as the remaining amount, mixing while stirring at a speed of 50 ~ 200rpm to prepare a mixture.
실험예Experimental example 1. 피부 보습 효과 확인 1. Check the skin moisturizing effect
실시예 1 및 비교예 1 내지 6에 대하여 피부 보습 효과를 확인하였다. 실험은 공지된 방법을 통해 진행하였다.For Example 1 and Comparative Examples 1 to 6, the skin moisturizing effect was confirmed. The experiment was conducted through a known method.
실험동물로는 7주령의 수컷 무모 생쥐(male HR-1, hairless mice, Japan SLC, Inc)를 중앙실험동물로부터 구입하여 1주 동안 적응시킨 후 사용하였다. 적응기간 중 일반 상태를 관찰하여 건강한 상태의 동물을 시험에 사용하였다. 사육환경은 온도 23±3℃, 습도 50±5%, 명암주기 12시간 (07:00-19:00/조명시간)으로 유지하였다. 시험기간 중 실험동물은 폴리카보네이트(polycarbonate) 케이지(200×320×145mm, Three-shine Co, Daejeon,Korea)에 군당 5마리로 사육하였고 사료는 마우스 전용사료 5L79 (Charles river, USA)를 자유급이하였으며, 음수는 자외선으로 소독한 상수도수를 자유급이하였다. 실시예 1 및 비교예 1 내지 6 각각에 대한 시료투여는 마우스 존대를 이용하여 경구 투여를 실시하였다. 투여기간은 총 8주로 주 5일 동안 투여하였다. 자외선 조사를 수행하였다. 자외선 조사는 대조군을 제외한 실시예 1 및 비교예 1 내지 6 중 일부 생쥐에 대하여 8주 동안 주 3회 실시하였고, 자외선은 UV 램프(Mineralight UV Display lamp, UVP, USA)를 사용하였다. 자외선 조사량은 1 내지 7주간은 60mJ/cm2, 8-12주는 90 mJ/cm2로 12 주 동안 조사하였다. 자외선 조사량은 광측정기(Delta OHM, Italy)를 이용하여 광량을 측정한 후, 조사시간으로 조절하였다.As experimental animals, 7-week-old male hairless mice (male HR-1, hairless mice, Japan SLC, Inc) were purchased from the central experimental animal and used after adaptation for 1 week. During the adaptation period, normal conditions were observed, and healthy animals were used for the test. The breeding environment was maintained at a temperature of 23±3℃, a humidity of 50±5%, and a light/dark cycle of 12 hours (07:00-19:00/lighting time). During the test period, the experimental animals were bred in polycarbonate cages (200 × 320 × 145 mm, Three-shine Co, Daejeon, Korea) at 5 animals per group. The negative water was supplied freely with tap water disinfected with ultraviolet light. Sample administration for each of Example 1 and Comparative Examples 1 to 6 was orally administered using a mouse zone. The administration period was 8 weeks in total, 5 days a week. UV irradiation was performed. UV irradiation was performed 3 times a week for 8 weeks for some mice in Example 1 and Comparative Examples 1 to 6, except for the control group, and UV lamps (Mineralight UV Display lamp, UVP, USA) were used. The amount of UV irradiation was 60 mJ/cm 2 for 1 to 7 weeks, and 90 mJ/cm 2 for 8-12 weeks. The amount of UV irradiation was adjusted by the irradiation time after measuring the amount of light using a photometer (Delta OHM, Italy).
피부수분량은 항온 및 항습 조건(23℃, 상대습도 50%)에서 코니오미터(Corneometer Courage & Khazaka,Germany) 장비를 이용하여 피부에 함유된 수분을 측정하였다. 피부의 표피 내에 존재하는 수분의 양은 센서를 이용하여 수분의 이온 정도를 측정하고, 이를 수치화하여 수분 함유량(Capacitance(AU))을 계산함으로써 보습력을 측정하였다. 본 실시예에서 획득한 결과는 통계분석 프로그램(one-way ANOVA와 Student t-test)을 이용하여 대조군과 실시예 및 비교예 간의 유의성을 검정하였다. For the amount of skin moisture, moisture contained in the skin was measured using a Corneometer Courage & Khazaka, Germany equipment under constant temperature and constant humidity conditions (23° C., 50% relative humidity). The amount of moisture present in the epidermis of the skin was measured by measuring the ion level of moisture using a sensor, and calculating the moisture content (Capacitance (AU)) by quantifying it. The results obtained in this Example were tested for significance between the control group and the Examples and Comparative Examples using a statistical analysis program (one-way ANOVA and Student t-test).
그 결과, 실시예 1은 자외선(UV) 조사군에 비래 수분함유량이 유의미 있게 높게 나타났다. 반면, 비교예 1 내지 5는 자외선 조사군과 대비하여 수분함유량이 비슷하거나 크지 않다. 이러한 결과를 토대로 실시예 1이 피부보습효과가 있음을 확인할 수 있었다.As a result, Example 1 showed that the flying moisture content was significantly higher in the ultraviolet (UV) irradiation group. On the other hand, Comparative Examples 1 to 5 were not similar or large in moisture content compared to the UV irradiation group. Based on these results, it was confirmed that Example 1 had a skin moisturizing effect.
실험예Experimental example 2. 체지방 감소 효과 확인 2. Confirm the effect of reducing body fat
실시예 1 및 비교예 1 내지 6에 대하여 다이어트효과를 측정하기 위하여 다음과 같은 실험을 실시하였다. 실험은 공지된 방법을 통해 진행하였다.In order to measure the diet effect for Example 1 and Comparative Examples 1 to 6, the following experiment was performed. The experiment was conducted through a known method.
실험동물로서 생후 3주령인 SD rat(male, SPF, 150 - 200 g, 오리엔트바이오사로부터 구입)를 처리 군당 4수 3반복으로 각각 12수 난괴법(randomized complete block design)으로 배치하였고, 8주간 사육하며 실시예 1 및 비교예 1 내지 6과 함께 사료를 급식시켰다. 8주 후 체중을 측정하여 각 군(12마리)의 평균체중을 구하고, 8주 실험 완료 후 해부하여 장기 및 정소상체지방패드(EFP, 체지방)무게를 측정하였다. 체중 변화는 표 2에 나타내었고, 8주 후 정소상체지방패드 무게는 표 3에 나타내었다.As experimental animals, SD rats (male, SPF, 150 - 200 g, purchased from Orient Bio), aged 3 weeks, were placed in a 12-numbered egg mass method (randomized complete block design) in 4 repetitions per treatment group, respectively, for 8 weeks. The feed was fed together with Examples 1 and Comparative Examples 1 to 6 while breeding. After 8 weeks, body weight was measured to obtain the average weight of each group (12 animals), and after 8 weeks of experimentation, the organs and epididymal fat pad (EFP, body fat) weights were measured by dissection. The weight change is shown in Table 2, and the weight of the epididymal fat pad after 8 weeks is shown in Table 3.
그 결과, 실시예 1의 조성물이 비교예 1 내지 6의 조성물에 비해 체중 감소 및 체지방 감소 효과가 높은 것으로 나타났다.As a result, it was found that the composition of Example 1 had higher weight loss and body fat reduction effects than the compositions of Comparative Examples 1 to 6.
실험예Experimental example 3. 위염 개선 효과 확인 3. Confirm the effect of improving gastritis
실시예 1 및 비교예 1 내지 6에 대하여 위염 예방 효과를 확인하였다. 실험은 공지된 방법을 통해 진행하였다.For Example 1 and Comparative Examples 1 to 6, the effect of preventing gastritis was confirmed. The experiment was conducted through a known method.
실시예 1 및 비교예 1 내지 6을 각각 0.1% CMC에 녹여 SD rat(male, SPF, 150 - 200 g, 오리엔트바이오사로부터 구입)에 경구투여 하였다. 1시간 후에 indomethacin을 10 mg/rat의 용량으로 SD rat에 경구 투여하였다. 5시간 후 위부분을 절제하고 polytron homogenizer로 갈고, 원심분리하여 상등액을 얻었다. 이후 ethyl acetate로 추출하고 건조하였다. 이 후 methanol에 녹인 후 Park등의 방법으로(Eur. J. Pharmacol. 425, 153-157, 2001) Sep-Pak C18 column에 넣고 유출한 후 N2로 건조한 후 ELISA 법으로 위의 염증의 parameter인 PGE 2의 양을 정량하고 그 결과를 표 4에 나타내었다. 억제율은 아무것도 가하지 않은 실험군(Control)에 대한 백분율로 나타내었다.Example 1 and Comparative Examples 1 to 6 were each dissolved in 0.1% CMC and orally administered to SD rats (male, SPF, 150 - 200 g, purchased from Orient Bio). One hour later, indomethacin was orally administered to SD rats at a dose of 10 mg/rat. After 5 hours, the stomach was excised, ground with a polytron homogenizer, and centrifuged to obtain a supernatant. Then, it was extracted with ethyl acetate and dried. After that, it was dissolved in methanol and put into a Sep-Pak C18 column by Park et al. (Eur. J. Pharmacol. 425, 153-157, 2001), drained, dried with N2, and then PGE, a parameter of gastric inflammation, by ELISA method. The amount of 2 was quantified and the results are shown in Table 4. The inhibition rate was expressed as a percentage with respect to the experimental group to which nothing was added (Control).
(Mean ± SD)PGE (ng/stomach)
(Mean ± SD)
그 결과, 실시예 1의 조성물이 비교예 1 내지 6의 조성물에 비해 위염 억제율이 높은 것으로 나타났다.As a result, it was found that the composition of Example 1 had a higher rate of suppression of gastritis than the compositions of Comparative Examples 1 to 6.
실험예Experimental example 4. 위궤양 개선 효과 확인 4. Confirmation of gastric ulcer improvement effect
실시예 1 내지 2 및 비교예 1 내지 4에 대하여 위궤양 예방 효과를 확인하였다. 실험은 공지된 방법을 통해 진행하였다.For Examples 1 to 2 and Comparative Examples 1 to 4, the gastric ulcer prevention effect was confirmed. The experiment was conducted through a known method.
실시예 1 및 비교예 1 내지 6을 각각 0.1% CMC에 녹여 SD rat(male, SPF, 150 - 200 g, 오리엔트바이오사로부터 구입)에 경구투여 하였다. 그 후 위궤양을 유도하기 위하여 Rao등의 방법(J. Ethnopharmacol. 91, 243, 2004)에 따라, 1시간 후 ethanol을 경구 투여한 다음 4시간 경과 후 rat를 sacrifice하고 위를 절제한 후 formalin에 고정하고 궤양의 넓이를 측정하고 그 결과를 표 5에 나타내었다. 대조군으로는 오메프라졸 5 mg을 사용하였다. 억제율은 에탄올만 처리한 실험군(Ethanol-treated)에 대한 백분율로 나타내었다.Example 1 and Comparative Examples 1 to 6 were each dissolved in 0.1% CMC and orally administered to SD rats (male, SPF, 150 - 200 g, purchased from Orient Bio). After that, according to the method of Rao et al. (J. Ethnopharmacol. 91, 243, 2004) to induce gastric ulcer, ethanol was orally administered 1 hour later, and 4 hours later, the rats were sacrificed, the stomach was excised, and fixed in formalin. and the area of the ulcer was measured, and the results are shown in Table 5. As a control group, 5 mg of omeprazole was used. The inhibition rate was expressed as a percentage of the experimental group treated with ethanol only (Ethanol-treated).
그 결과, 실시예 1의 조성물이 비교예 1 내지 6의 조성물에 비해 위궤양 억제율이 높은 것으로 나타났다.As a result, it was found that the composition of Example 1 had a higher rate of suppression of gastric ulcer than the compositions of Comparative Examples 1 to 6.
실험예Experimental example 5. 여성갱년기 증후군 개선 효과 확인 5. Confirmation of improvement effect on female menopausal syndrome
실시예 1 내지 2 및 비교예 1 내지 4에 대하여 여성갱년기 증후군 예방 효과를 확인하였다. 실험은 공지된 방법을 통해 진행하였다.For Examples 1 to 2 and Comparative Examples 1 to 4, the preventive effect of female menopausal syndrome was confirmed. The experiment was conducted through a known method.
폐경을 전후로 갱년기 증후군 증상을 보이는 40 내지 65세의 여성 100명을 대상으로 무작위로 5명씩 13개의 군으로 나누어 실시예 1 및 비교예 1 내지 6을 1회 20ml, 1일 2회씩 8주간 복용하고, 갱년기 주요 증상인 안면홍조, 발한, 불면증, 과민성, 우울증, 어지럼증, 피로감, 관절 및 근육통, 두통, 가슴 두근거림, 질 건조의 11가지 항목에 대해 각 항목의 개선여부를 5점 척도(0점은 효과가 없음을, 5점은 효과가 있음을 나타낸다.)로 표시하여 평균수치를 구하고, 그 결과를 표 6에 나타내었다.After menopause, 100 women aged 40 to 65 years old with menopausal syndrome symptoms were randomly divided into 13 groups of 5 people each, and 20 ml of Examples 1 and 1 to 6 were taken twice a day for 8 weeks. , on a 5-point scale (0 points) for each of the 11 items, including hot flashes, sweating, insomnia, irritability, depression, dizziness, fatigue, joint and muscle pain, headache, chest palpitations, and vaginal dryness, which are the main symptoms of menopause. indicates that there is no effect, and 5 indicates that there is an effect) to obtain the average value, and the results are shown in Table 6.
(4주 후)Menopause symptom index
(After 4 weeks)
(8주 후)Menopause symptom index
(After 8 weeks)
그 결과, 실시예 1의 조성물이 비교예 1 내지 6의 조성물에 비해 갱년기 증후군의 증상 개선 효과가 높은 것으로 나타났다.As a result, it was found that the composition of Example 1 had a higher effect of improving symptoms of menopausal syndrome than the compositions of Comparative Examples 1 to 6.
결론.conclusion.
상기 실시예, 비교예 및 실험예를 통하여, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 효과를 확인하였다.Through the Examples, Comparative Examples and Experimental Examples, the effect of the food composition comprising the pineapple-derived ceramide according to the present invention as an active ingredient was confirmed.
실험예 1을 통하여, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 피부 보습효과가 있음을 확인하였다.Through Experimental Example 1, it was confirmed that the food composition comprising the pineapple-derived ceramide according to the present invention as an active ingredient has a skin moisturizing effect.
또한, 실험예 2을 통하여, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 체지방 감소 효과가 있음을 확인하였다.In addition, through Experimental Example 2, it was confirmed that the food composition comprising the pineapple-derived ceramide according to the present invention as an active ingredient has an effect of reducing body fat.
또한, 실험예 3 및 4을 통하여, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 위염 및 위궤양 개선 효과가 있음을 확인하였다.In addition, through Experimental Examples 3 and 4, it was confirmed that the food composition containing the pineapple-derived ceramide according to the present invention as an active ingredient has an effect of improving gastritis and gastric ulcer.
또한, 실험예 5를 통하여, 본 발명에 따른 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물은 여성 갱년기 증후군 개선 효과가 있음을 호가인하였다.In addition, through Experimental Example 5, it was confirmed that the food composition comprising the pineapple-derived ceramide according to the present invention as an active ingredient has an effect of improving female menopausal syndrome.
이에, 본 발명은 피부 보습 효과는 물론, 체중 감소 효과, 위염 또는 위궤양 개선 효과, 여성갱년기 증후군 개선 효과 등 다양한 효과를 갖도록 한 신규한 기능성 식품 조성물로써, 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물을 개발하였음을 명시한다.Accordingly, the present invention is a novel functional food composition that has various effects such as skin moisturizing effect, weight loss effect, gastritis or gastric ulcer improvement effect, and female menopausal syndrome improvement effect, and a food composition comprising pineapple-derived ceramide as an active ingredient indicate that it has been developed.
본 발명을 첨부된 도면과 함께 설명하였으나, 이는 본 발명의 요지를 포함하는 다양한 실시 형태 중의 하나의 실시 예에 불과하며, 당 업계에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 하는 데에 그 목적이 있는 것으로, 본 발명은 상기 설명된 실시예에만 국한되는 것이 아님은 명확하다. 따라서, 본 발명의 보호범위는 하기의 청구범위에 의해 해석되어야 하며, 본 발명의 요지를 벗어나지 않는 범위 내에서 변경, 치환, 대체 등에 의해 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리에 포함될 것이다. 또한, 도면의 일부 구성은 구성을 보다 명확하게 설명하기 위한 것으로 실제보다 과장되거나 축소되어 제공되는 것임을 명확히 한다.Although the present invention has been described in conjunction with the accompanying drawings, this is only one embodiment of various embodiments including the gist of the present invention, and is intended to be easily implemented by those of ordinary skill in the art. For the purpose, it is clear that the present invention is not limited to the embodiments described above. Accordingly, the protection scope of the present invention should be interpreted by the following claims, and all technical ideas within the scope equivalent to that by changes, substitutions, substitutions, etc. within the scope not departing from the gist of the present invention are in the right of the present invention. will be included In addition, it is clarified that some components of the drawings are provided in an exaggerated or reduced form than in reality for more clearly explaining the configuration.
(S10): 원료 준비 단계
(S20): 원료 혼합 단계
(S30): 숙성 단계(S10): raw material preparation step
(S20): raw material mixing step
(S30): ripening stage
Claims (5)
A food composition comprising pineapple-derived ceramide as an active ingredient, characterized in that it comprises pineapple-derived ceramide, collagen, mango ginger extract, and Java pepper extract.
상기 망고진저 추출물 및 자바후추 추출물은 각각 망고진저와 자바후추를 정제수, 에탄올, 부탄올, 부틸렌글라이콜 또는 이소프로판올 중 어느 하나 이상의 추출용매로 추출한 것을 특징으로 하는 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물.
According to claim 1,
The mango ginger extract and Java pepper extract, respectively, are obtained by extracting mango ginger and Java pepper with at least one extraction solvent of purified water, ethanol, butanol, butylene glycol, or isopropanol. Food containing ceramide derived from pineapple as an active ingredient composition.
상기 원료 준비 단계(S10)에서 준비된 파인애플 유래 세라마이드, 콜라겐, 망고진저 추출물 및 자바후추 추출물을 혼합하여 혼합물을 제조하는 원료 혼합 단계(S20) 및;
상기 원료 혼합 단계(S20)에서 제조된 혼합물을 숙성하는 숙성 단계(S30);를 포함하는 것을 특징으로 하는 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조방법.
Raw material preparation step of preparing pineapple-derived ceramide, collagen, mango ginger extract and Java pepper extract (S10);
A raw material mixing step (S20) of preparing a mixture by mixing the pineapple-derived ceramide, collagen, mango ginger extract and Java pepper extract prepared in the raw material preparation step (S10) and;
A method of producing a food composition comprising a pineapple-derived ceramide as an active ingredient, comprising a; aging step (S30) of aging the mixture prepared in the raw material mixing step (S20).
상기 원료 준비 단계(S10)의 상기 망고진저 추출물 및 자바후추 추출물은 각각 망고진저와 자바후추를 정제수, 에탄올, 부탄올, 부틸렌글라이콜 또는 이소프로판올 중 어느 하나 이상의 추출용매로 추출한 것을 특징으로 하는 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조방법.
4. The method of claim 3,
The mango ginger extract and Java pepper extract of the raw material preparation step (S10) are pineapple-derived, characterized in that mango ginger and Java pepper are extracted with at least one extraction solvent of purified water, ethanol, butanol, butylene glycol, or isopropanol, respectively A method for producing a food composition comprising ceramide as an active ingredient.
상기 숙성 단계(S30)는 12 내지 48시간 동안 10 ~ 25℃로 이루어지는 것을 특징으로 하는 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물의 제조방법.4. The method of claim 3,
The aging step (S30) is a method for producing a food composition comprising a pineapple-derived ceramide as an active ingredient, characterized in that it consists of 10 ~ 25 ℃ for 12 to 48 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200073754A KR102389105B1 (en) | 2020-06-17 | 2020-06-17 | Food composition containing pineapple-derived ceramide as an active ingredient and method for manufacturing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200073754A KR102389105B1 (en) | 2020-06-17 | 2020-06-17 | Food composition containing pineapple-derived ceramide as an active ingredient and method for manufacturing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210156387A KR20210156387A (en) | 2021-12-27 |
KR102389105B1 true KR102389105B1 (en) | 2022-05-06 |
Family
ID=79177196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200073754A KR102389105B1 (en) | 2020-06-17 | 2020-06-17 | Food composition containing pineapple-derived ceramide as an active ingredient and method for manufacturing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102389105B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160220627A1 (en) | 2015-01-30 | 2016-08-04 | Dharma Biomedical, Llc | Extracts of curcuma amada and uses thereof |
JP2017052706A (en) | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE239687T1 (en) * | 1998-01-09 | 2003-05-15 | Eurovita As | CERTAIN DITERPENES, EXTRACTS OR CONCENTRATES OF CURCUMA AMADA CONTAINING SAME FOR USE AS MEDICATIONS |
JP4680571B2 (en) | 2003-12-25 | 2011-05-11 | カルピス株式会社 | Moisturizer for ingestion |
EP2162117B1 (en) * | 2007-05-31 | 2018-02-21 | Anterios, Inc. | Nucleic acid nanoparticles and uses therefor |
-
2020
- 2020-06-17 KR KR1020200073754A patent/KR102389105B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160220627A1 (en) | 2015-01-30 | 2016-08-04 | Dharma Biomedical, Llc | Extracts of curcuma amada and uses thereof |
JP2017052706A (en) | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
Also Published As
Publication number | Publication date |
---|---|
KR20210156387A (en) | 2021-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101584742B1 (en) | Cosmetic composition for improving skin-aging | |
KR101023503B1 (en) | Composition for external use | |
KR100934252B1 (en) | Its feed and an additive composition for poultry containing wild ginseng cultured root | |
KR101956533B1 (en) | Functional pet food to prevent dental calculus and plaque and method for producing the same | |
Ighodaro et al. | Effects of Nigerian Piliostigma thonningii species leaf extract on lipid profile in Wistar rats | |
WO1999038479A1 (en) | Banana peel extract composition and method for extraction | |
Chikezie | Phytochemical and proximate composition of Tetracarpidium conophorum (African Walnut) seeds | |
KR102358623B1 (en) | Food composition for improving skin condition comprising collagen peptide | |
KR102389105B1 (en) | Food composition containing pineapple-derived ceramide as an active ingredient and method for manufacturing the same | |
JP2006219432A (en) | Composition having rough skin-preventing activity, cosmetic and beverage | |
KR20100080111A (en) | Feed additives comprising extracts of opuntia humifusa | |
JP2010254667A (en) | Collagen gel shrinking agent | |
CN105380873B (en) | A kind of replenishing water and preserving moisture essence containing oil of Nitraria seeds | |
KR100911279B1 (en) | Feed mixture for replacing antibiotics | |
KR20150067597A (en) | Maximowiczia Chinensis Extracts For improvement Of Muscel Antioxidant Activity And Manufacturing Method of thereof | |
KR101939535B1 (en) | Feed additives containing cyanidin-3-glucoside and method of preparing the same | |
Kimura et al. | Sparassis crispa (Hanabiratake) ameliorates skin conditions in rats and humans | |
KR102093741B1 (en) | Manufacturing method of instant food salad | |
KR20120114523A (en) | Korean cattle feed manufacturing method and korean cattle feed manufactured by the same | |
KR101521083B1 (en) | External agent for skin comprising extract of cudrania tricuspidata | |
JP5798294B2 (en) | Collagen gel shrinking agent | |
US8003142B2 (en) | Therapeutic and cosmetic balsam | |
Kouguchi et al. | Vasoprotective effect of foods as treatments: chicken collagen hydrolysate | |
KR102651344B1 (en) | Food composition for anti-inflammatory, muscle building, joint health and cartilage health improvement | |
KR101944261B1 (en) | Wrinkle cosmetic composition containing collagen to chicken feet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right |